{"id":"W2599229094","doi":"10.1200/jco.2017.35.6_suppl.458","title":"Sunitinib dose escalation after disease progression in metastatic renal cell carcinoma.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Sunitinib; Renal cell carcinoma; Toxicity; Internal medicine; Progression-free survival; Tumor progression; Clear cell renal cell carcinoma; Oncology; Retrospective cohort study; Surgery; Urology; Cancer; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001361817,0.0001259987,0.0006431561,0.0004563668,0.0001806749,0.0003618342,0.0002560155,0.0002026194,0.0006425716],"category_scores_gemma":[0.001157941,0.00007982024,0.0005019339,0.0006625396,0.0001690048,0.0002334709,0.0001460399,0.0003096074,0.0001299265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007391886,"about_ca_system_score_gemma":0.0004821042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004484282,"about_ca_topic_score_gemma":0.001243329,"domain_scores_codex":[0.9994962,0.0001730357,0.00008119833,0.00009310146,0.0001205144,0.00003596765],"domain_scores_gemma":[0.9990898,0.0002442652,0.0005213139,0.00004057993,0.00004810515,0.00005592831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01941083,0.0009051065,0.355572,0.004705581,0.001627705,0.002067284,0.0005064718,0.005150231,0.05434848,0.0003964131,0.002099699,0.5532102],"study_design_scores_gemma":[0.002442179,0.04085217,0.8783421,0.0004360054,0.00139509,0.01701815,0.0001943735,0.003155858,0.03440527,0.0004832913,0.02123673,0.00003887365],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9781277,0.01927692,0.0005050645,0.0001202983,0.00001264779,0.0001596764,0.0003077027,0.00003375403,0.001456319],"genre_scores_gemma":[0.9967396,0.002359819,0.0004146871,0.0000589331,0.0000206397,0.00004386299,0.0001986484,0.000003441101,0.0001603845],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001361817,"threshold_uncertainty_score":0.007202089,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1550953964425187,"score_gpt":0.4776115582056026,"score_spread":0.3225161617630839,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}